跳至主要内容
临床试验/NCT02993744
NCT02993744已完成不适用

Assessment of Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone Under Threat of Preterm Delivery

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
140
试验地点
1
主要终点
CRP

研究概览

简要总结

It is the aim of this study to detect the effect of Betamethasone on the maternal inflammatory parameters C-reactive protein (CRP) and leukocytes of a pregnant woman under threat of preterm delivery, for example because of a cervical infection.

详细描述

BACKGROUND

Cortisone influences the maternal number of leukocytes and CRP of a pregnant woman. Because of that, it is difficult to know if the medical treatment of an infection was successful and accordingly if the diagnosis was justified.

METHODS

In this study, the blood results of 75 pregnant women under threat of preterm delivery (week of gestation 23+0 to 34+6), treated with Betamethasone will be analysed. 65 pregnant women without complications serve as control group.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • week of gestation 23+0 until 34+6

排除标准

  • infectious diseases f.e. hepatitis B or C, HIV
  • diseases of the thyroid gland
  • 75 Patients facing preterm labour 65 Patients acting as a control group, without preterm labor

结局指标

主要结局

CRP

时间窗: 48h

The CRP values in mg/dL before and 48h after the first Betamethasone application

次要结局

  • Leucocytes(48h)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kastanek Maria

Student

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验